Last Updated: November 9, 2026

Patent: 12,144,861

Summary for Patent: 12,144,861

Title:	Pharmaceutical product with increased stability comprising immunoglobulins
Abstract:	The present invention pertains to a pharmaceutical product comprising a polyclonal immunoglobulin solution in a pre-filled polymer syringe in secondary packaging comprising an oxygen scavenger.
Inventor(s):	Renzo Pedrussio, Regula Styger
Assignee:	CSL Behring AG
Application Number:	US15/532,378
Patent Claims:	see list of patent claims

Details for Patent 12,144,861

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Csl Behring Ag	RHOPHYLAC	rho(d) immune globulin intravenous (human)	Injection	125070	February 12, 2004	⤷ Start Trial	2035-12-03
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

International Patent Family for US Patent 12,144,861

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration
Australia	2015357068	⤷ Start Trial
Brazil	112017010442	⤷ Start Trial
Canada	2968915	⤷ Start Trial
China	106999588	⤷ Start Trial
China	121371151	⤷ Start Trial
Denmark	3226895	⤷ Start Trial
Denmark	3763384	⤷ Start Trial
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.